Comparison of the Effect of Two Anaesthesia Methods in Preventing Perioperative Myocardial Infarcation in Patients With Cardiac Risk Undergoing Total Knee Arthroplasty

Myocardial Ischaemia Clinical Trial

Official title:
Comparison of the Effect of Two Anaesthesia Methods in Preventing Perioperative Myocardial Infarction in Patients With Cardiac Risk Undergoing Total Knee Arthroplasty

Status Completed

Clinical Trial Summary

Comparison of the effect of two anaesthesia methods in preventing perioperative myocardial infarction in patients with cardiac risk undergoing total knee arthroplasty

Clinical Trial Description

we enrolled 50 patients of both sex of American society of Anesthesiologists (ASA) physical status II where the presence and/or risk for coronary artery disease (CAD) as well as planned lower extremity surgery was considered. Presence of CAD was ascertained by history of myocardial infarction and diagnosis of typical angina or atypical angina with a positive stress test & ECG finding. Risk for CAD included age (> 65 years old), hypertension, smoking habit, blood cholesterol (>240 mg/dL), and diabetes. who met the selection criteria were randomly allocated to 1 of the 2 groups (25 patients) each: - Group (G): received general anaesthesia followed by IV patient-controlled analgesia (IV PCA). - Group (F): received spinal anaesthesia followed by continuous ultrasound guided femoral never block once the anaesthesia-induced motor block resolved. We aimed to compare the effect of the two anaesthesia methods in preventing perioperative myocardial infarction in patients with cardiac risk undergoing total knee arthroplasty. The primary outcome included perioperative levels of brain natriuretic peptide & cardiac troponins. Secondary outcomes included postoperative operative pain assessment using visual analogue scale, total amount of analgesic consumption, patient satisfaction & cardiovascular complications (myocardial infarction, arrhythmias , heart failure, hypotension, hypertension & the need for inotropic agents). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05340946
Study type	Interventional
Source	Alexandria University
Contact
Status	Completed
Phase	N/A
Start date	September 5, 2021
Completion date	April 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01035567` - Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery Disease	Phase 2/Phase 3
Not yet recruiting	`NCT05824520` - Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy	N/A
Not yet recruiting	`NCT00311259` - Melatonin Treatment and Inflammation, Oxidative Stress and Autonomic Function in Connection With Surgery	Phase 2
Completed	`NCT02095964` - HDL-C in Cardiac Syndrome X	N/A
Recruiting	`NCT04575207` - The Flash FFR Ⅱ Study	N/A
Active, not recruiting	`NCT03656848` - The FAVOR III China Study	N/A
Completed	`NCT01236807` - MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease	N/A
Completed	`NCT00657527` - Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease	Phase 3
Recruiting	`NCT04470934` - SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)